In inflammatory bowel diseases, a breakdown in host microbial interactions accompanies sustained activation of immune cells in the gut. Functional studies suggest a key role for interleukin-23 (IL-23) in orchestrating intestinal inflammation. IL-23 can be produced by various mononuclear phagocytes (MNPs) following acute microbial stimulation, but little is known about the key cellular sources of IL-23 that drive chronic intestinal inflammation. Here we have addressed this question using a physiological model of bacteria-driven colitis. By combining conditional gene ablation and gene expression profiling, we found that IL-23 production by 
INTRODUCTION
Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract commonly associated with high morbidity. The precise etiology of inflammatory bowel diseases is unknown, but involves a complex combination of host genetic, microbial, and environmental factors that alter mucosal immune responses. 1 In healthy individuals, intestinal homeostasis is ensured through the tight control of aberrant immune responses by a complex regulatory network. Distinct subsets of mononuclear phagocytes (MNPs) are strategically located at the mucosal interface, residing either in gut-associated lymphoid tissue or dispersed throughout the lamina propria. Within these sites, two major populations of MNPs can be identified:
2 classical dendritic cells (DCs), expressing the integrins CD11c and CD103 (a E b 7 ) with or without coexpression of CD11b, and monocyte-derived MNPs, expressing the fractalkine receptor (CX 3 CR1), CD11b, and various levels of CD11c. In addition, two minor populations of DCs can be found: CD103 -CD11b þ CX 3 CR1 int and CD103 -CD11b -CX 3 CR1 -DCs. 3 Lamina propria CD103
þ DCs arise from common DC progenitors and classical DC-committed precursor under the control of Fms-like tyrosine kinase 3 ligand. CD103
þ CD11b þ DCs are predominantly located in the small intestine, where they constitutively sample antigen and migrate to the mesenteric lymph nodes to prime and polarize naive T cells. 4, 5 In contrast, the colon mostly harbors CD103
þ CD11b -DCs 6 that are developmentally related to lymphoid-tissue resident CD8a þ DCs. 7 In addition to classical DCs, a network of macrophages expressing high levels of CD11c and CX 3 CR1 is spread 1 Translational Gastroenterology Unit, Experimental Medicine Division-NDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.
throughout the intestinal lamina propria. These cells contrast with macrophage populations in other tissues by their relatively short life span and their constitutive replenishment from the blood monocyte pool. [8] [9] [10] Under homeostatic conditions, Ly6C hi monocytes entering the gut transit through a continuum of developmental intermediates before giving rise to fully mature CX 3 CR1 hi macrophages. This process involves the stepwise acquisition of anti-inflammatory genes along with the expression of the major histocompatibility complex class II (MHCII) and downregulation of typical proinflammatory genes. 11, 12 Ly6C hi monocytes also give rise to a heterogeneous Ly6C lo CX 3 CR1 int cellular subset distinct from macrophages that share characteristics of macrophages and DCs 11, 13 and can be distinguished by their differential expression of the tissue macrophage marker Fc gamma receptor 1 (CD64) 14, 15 and F4/80.
Lately, many studies have highlighted the critical roles of these complementary subsets in shaping both homeostatic and inflammatory responses. 5, 16, 17 Their precise roles in inflammation are only beginning to be unraveled, and definitive reports on their functional contribution to chronic intestinal inflammation are currently lacking.
Interleukin-23 (IL-23) is a heterodimeric cytokine comprising the IL-12p40 and IL-23p19 subunits. 18 It has been well documented as a critical driver of multiple inflammatory conditions in mice and humans, and plays a key role in the pathogenesis of inflammatory bowel diseases. 19, 20 Although the mechanism through which IL-23 drives intestinal inflammation has been studied extensively, little is known about the cellular sources implicated in the generation of IL-23-dependent intestinal inflammation in vivo. In this study, we used a bacterially driven model of intestinal inflammation with many cardinal features of human inflammatory bowel diseases to address the functional relevance of IL-23 production by CD11c þ antigen-presenting cells and to characterize the cellular subsets involved in this key pathophysiological process.
RESULTS

H. hepaticus-driven inflammation alters the intestinal mononuclear phagocyte compartment
The Gram-negative bacterium Helicobacter hepaticus (Hh) is a noninvasive organism commonly found in the mucosal layer of the murine lower intestinal tract. Wild-type animals infected with the bacterium do not develop intestinal immunopathology and serve as carriers of the infection. 21 However, mice with genetic deficiencies in the IL-10/IL-10R pathway are susceptible to experimental Hh infection and develop severe inflammation of the colon and cecum (typhlocolitis) associated with epithelial hyperplasia. 22, 23 Similarly, Hh infection of wildtype mice with concomitant administration of anti-IL-10R monoclonal antibodies (mAbs) triggers IL-23-dependent intestinal inflammation along with a robust T helper type 1/type 17 (Th1/Th17)-polarized effector T cell response. 23 Mice infected with Hh and treated with anti-IL-10R antibodies, but not uninfected or single-treated controls, develop histological features of colitis within 2-3 weeks after infection Figure S1a) . At steady state, MHCII þ monocytes and macrophages express the mannose receptor (CD206), a marker associated with anti-inflammatory macrophage function. 24 However, expression of CD206 was lower in MHCII þ monocytes and macrophages during colitis (Figure 1f ), suggesting that not only monocyte but also macrophage functions were modified during inflammation. Indeed, we found that during inflammation, MHCII þ monocytes expressed higher amounts of tumor necrosis factor-a and IL-6 protein, and Nos2 (inducible nitric oxide synthase) mRNA, and that IL-6 was also increased in macrophages (Supplementary Figure S1c) . IL-10 production by both MHCII þ monocytes and macrophages was also increased during inflammation (Supplementary Figure S1c) , most likely reflecting an inflammation-driven negative feedback pathway.
Besides their differentiation into macrophages, MHCII þ DCs express MHCII, CD24, and CD11c, but lack expression of CD64 and F4/80, markers commonly associated with macrophages ( Figure 1d and Supplementary Figure S1b) . However, the distinction between macrophages and CD11b þ DCs was blurred during inflammation by the appearance of a CD64-expressing population (Figure 1d ,e) and it is currently unclear how these cells ontogenically and functionally relate to steady-state macrophages or CD11b þ DCs. During colitis, the marked accumulation of MHCII þ monocytes correlated with a reduced frequency of macrophages, CD11b
þ DCs, and CD103 þ DCs (defined as CD11c
-cells, orange subset) among CD45 þ lamina propria cells (Figure 1c,d) . However, absolute numbers indicated a small increase in CD11b þ DCs and CD103 þ CD11b þ DCs. In contrast, the numbers of macrophages remained unchanged and CD103 þ CD11b -DCs were slightly decreased (Supplementary Figure S1a) .
Altogether, Hh infection in the presence of IL-10R blockade triggers intestinal inflammation associated with dramatic ARTICLES MucosalImmunology | VOLUME 9 NUMBER 2 | MARCH 2016 changes in the myeloid compartment. We observed the predominant accumulation of granulocytes and MHCII þ monocytes within the colonic lamina propria. In addition, MHCII þ monocytes and macrophages acquired a more proinflammatory profile.
CD11c
þ mononuclear phagocytes drive colitis through the production of IL-23
Because IL-23 has been identified as the major driver of colitis in this model, 23 we next investigated the functional relevance of IL-23 production by mononuclear phagocytes in the development of colitis in the Hh þ anti-IL-10R model. Therefore, we crossed mice expressing green fluorescent protein (GFP) and Cre recombinase under the control of the CD11c promoter (encoded by Itgax) 25, 26 with mice possessing two loxP sites flanking four exons of the Il23a gene 27 to generate Cd11c-cre.Il23a fl/fl (CD11c IL-23-) mice. As CD11c IL-23-mice express GFP under the control of the CD11c promoter and therefore cannot be crossed to CX 3 CR1-GFP reporter mice, we relied on an alternative gating strategy to assess the myeloid compartment in these mice (Supplementary Figure S2) . At steady state, CD11c
IL-23-mice had similar numbers of leukocytes in the colon as their IL-23-proficient littermates (CD11c IL-23 þ ) (Supplementary Figure S3a) and Figure S3b) . However, as IL-23 is required for maintaining differentiated Th17 cells, 28 
IL-23-mice displayed strongly reduced levels of IL-17 Figure S3c) .
cells in the colon (Supplementary
Upon infection with Hh and anti-IL-10R treatment, CD11c
IL-23-mice exhibited a striking reduction in colitis compared with CD11c IL-23 þ mice, with reduced epithelial crypt hyperplasia and lower leukocyte infiltration throughout the colon and cecum (Figure 2a,b) . CD11c IL-23-mice also showed no development of splenomegaly (Figure 2c ), indicating that they were also protected from systemic signs of disease. Reduced pathology observed in CD11c IL-23-mice was not a consequence of a differential bacterial load, as Hh colonization levels were similar in CD11c IL-23-and CD11c IL-23 þ groups ( Figure 2d ). Consistent with reduced pathological changes, both innate and adaptive effector cytokines were strongly reduced in the colon of IL-23-mice correlated with a higher frequency of lamina propria macrophages, whereas the frequencies of CD11b þ DCs and CD103 þ DCs were unchanged and absolute numbers were reduced (Supplementary Figure S3d ).
Because IL-23 drives intestinal inflammation through direct effects on T cells, promoting their accumulation and proliferation in the colon, 29 we examined the colonic T cell compartment of CD11c
IL - 
IL-23-mice showed only mild induction of the corresponding cytokines ( Figure 3c) .
Overall, the absence of colitis in CD11c IL-23-mice indicates that the production of IL-23 by CD11c-expressing MNPs plays a nonredundant role in the intestinal inflammatory response. þ DCs among total leukocytes were unchanged at this time point (Figure 4d) .
To further characterize the myeloid subsets involved in IL-23-dependent intestinal inflammation, we examined CD11c-Cre-associated GFP expression by lamina propria cells from CD11c IL-23 þ mice. Analysis of CD45 þ cells confirmed that Cre-GFP expression was restricted to leukocytes expressing CD11c on their cell surface (Figure 4f ), but was predominantly observed in CD11c hi cells. Furthermore, Cre-associated GFP fluorescence was only observed in MHCII þ cells (Figure 4g ) and, interestingly, Il23a mRNA expression was restricted to Cre-GFP þ cells (Figure 4h ). The majority of lamina propria MNPs express high levels of CD11c (Figure 1e and Supplementary Figure S1b) . Analysis of distinct myeloid subsets in CD11c IL-23 þ mice revealed that CD11c-Cre-associated GFP expression was predominantly detected among macrophages, CD103
þ CD11b -DCs, CD103 þ CD11b þ DCs, (Figure 4i) , and CD11b þ DCs (not shown). In addition, more than half of MHCII þ monocytes were positive for Cre-GFP, indicating that all those subsets might be a potential source of IL-23. In contrast, Cre expression was absent from eosinophils, neutrophils, and MHCII -monocytes (Figure 4i ). As the level of CX 3 CR1 expression identifies discrete subsets of MNPs, we repeated our analysis in CX 3 CR1
GFP/ þ mice. In uninfected mice, low levels of constitutive Il23a were Figure S4c,d) , and CD11b þ DCs (Supplementary Figure S4d) . However, increased expression of Il23a 
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at 4 days following infection with Hh and IL-10R blockade was only consistently detected in MHCII
þ monocytes (Supplementary Figure S4d ) and macrophages (not shown). During the course of inflammation, high Il23a expression was maintained in MHCII þ monocytes and their developmental progeny, but not CD103 þ DCs (Figure 5a ). Among CX 3 CR1 int subsets, expression of Il23a was further restricted to CD64 þ cells (Figure 5b ). Taken together, our data indicate that induction of IL-23 in colitis is contained within CX 3 CR1-expressing CD11c þ cells that also express MHCII and CD64.
Batf3-dependent CD103
þ DCs are dispensable for chronic colitis
CD103
þ CD11b þ DCs are predominantly found in the mouse small intestine and are nearly absent from the colon. 6 Instead, most colonic CD103
þ DCs are CD11b -and require the transcription factor Batf3 for their development. 30 
Batf3
À / À mice therefore lack tissue-resident CD8a þ and CD103 þ CD11b -nonlymphoid DC subsets. As expected, CD103
þ CD11b -cells were strongly reduced in the colonic lamina propria of Batf3 À / À mice, whereas CD103 þ CD11b þ DCs were unaffected (Figure 6a,b) . To assess whether CD103 To decipher the contribution of macrophages to IL-23 production, we generated bone marrow-derived macrophages (BMDMs) from CD11c IL-23-and CD11c IL-23 þ mice. After differentiation with L929 cell-conditioned medium, around half of the BMDMs were positive for Cre-GFP and expressed CD64, F4/80, and CD11c (Supplementary Figure S5a) . BMDMs were stimulated in vitro with live Hh bacteria in the presence of anti-IL-10R antibody and their response was compared with the respective controls. Strikingly, stimulation of CD11c
IL-23 þ
BMDMs with Hh resulted in Il23a mRNA expression and this response was enhanced in the presence of IL-10R signaling blockade, whereas Il23a was not expressed by unstimulated BMDMs or those treated with anti-IL-10R antibody alone (Supplementary Figure S5b) . Similarly, infection of mice with Hh only induced a low burst of IL-23 in monocytes and macrophages in vivo and this response was strongly increased in the absence of IL-10R signaling (Supplementary Figure S5c) . Intestinal tissue macrophages exclusively derive from blood monocytes and do not self-renew. 8, 10 Colony-stimulating factor 1 receptor (CSF-1R) signaling controls the differentiation of Ly6C hi into Ly6C lo monocytes 31 and is required for the maturation and replacement of resident-type Ly6C lo monocytes and tissue macrophages, but is dispensable for Ly6C hi monocyte production or inflammatory function. 32 To assess the relative contributions of MHCII þ monocytes and tissue macrophages to the development of IL-23-dependent intestinal inflammation, we pretreated CX 3 CR1 GFP/ þ mice with an anti-CSF-1R-blocking mAb or isotype control before induction of colitis. A group of mice was analyzed at day 0 (Supplementary Figure S6a,b) , whereas the remaining mice were treated with Hh and anti-IL-10R and continued to receive anti-CSF-1R treatment. At 4 days after Hh infection and anti-IL-10R treatment, macrophages were almost absent from the colon of anti-CSF-1R-treated mice. The heterogeneous Ly6C lo CX 3 CR1 int macrophage/DC compartment was also significantly reduced in these mice (Figure 7a,b and Supplementary Figure S6c ). Although the total number of colonic leukocytes was unchanged (Figure 7c) , there was an increase in the proportion of granulocytes in these conditions (Figure 7d) . Interestingly, the depletion of macrophages further correlated with increased Il23a expression within the lamina propria at day 4 ( Figure 7e) . However, anti-CSF-1R-mediated depletion of macrophages throughout the whole course of colitis did not affect the number of inflammatory cells accumulating in the colon (Figure 7f) or the severity of intestinal pathology (Figure 7g ) 2 weeks following Hh infection and IL-10R signaling blockade, suggesting that MHCII þ monocytes and macrophages may exhibit functional redundancy during inflammation.
DISCUSSION
In this work, we show that intestinal CD11c þ mononuclear phagocytes play a nonredundant role in the inflammatory process triggered by Hh in the absence of IL-10R signaling through the production of IL-23. Both innate and adaptive immune responses were impaired in the absence of CD11c-restricted IL-23 production, preventing the characteristic intestinal infiltration of granulocytes, monocytes, and pathogenic T cells observed in this model. Multiple lamina propria MNPs express CD11c and analysis of Il23a gene expression from various colonic CD11c þ subsets identified MHCII þ monocytes and macrophages as the most abundant cellular sources of IL-23 during Hh þ anti-IL-10R-induced inflammation, supporting a functional contribution of these cells during colitis. In contrast, IL-23-driven colitis was independent of Batf3-dependent CD103 þ CD11b -DCs. These results are consistent with our previous studies showing a pathogenic role for infiltrating monocytes during T cell-driven colitis 16 and further show that production of IL-23 is a major determinant of this function. 
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Others have identified monocytes/macrophages as a source of IL-23 upon intestinal inflammation. [33] [34] [35] However, none of those studies have examined the relative expression of IL-23 by distinct MNP subsets in a systematic way nor have addressed the functional relevance of this expression in the context of chronic intestinal inflammation. This is mostly because of the difficulty of accurately identifying individual subsets of macrophages and DCs within the lamina propria owing to substantial overlap in their expression of surface markers.
Although CX 3 CR1 hi macrophages have been described as a decisive factor determining gut health and inflammation, 36 we have made the intriguing observation that intestinal macrophages dependent on CSF-1 for their survival were dispensable for the production of Il23a and development of colitis in our model. This indicates that newly recruited monocytes entering the lamina propria from the blood do not require full differentiation to launch a proinflammatory response and can drive colitis in the absence of macrophages. It further suggests that fully mature macrophages share some functional redundancy with MHCII þ monocytes regarding the production of IL-23. This observation is in line with the distinctive origin of intestinal macrophages, which are replenished exclusively from the blood monocyte pool through a series of developmental intermediates. 10 Blood monocytes show induction of MHCII after or in concert with their arrival into tissues, possibly through interaction with the endothelium. 37 Our observation that both MHCII -and CD64 -subsets do not express Il23a suggests that the induction of IL-23 occurs in a particular, more mature monocyte developmental stage coinciding with the upregulation of MHCII and CD64.
DC-derived IL-23 has been shown to be involved in both homeostatic and inflammatory mucosal functions. Thus, interferon regulatory factor 4-dependent CD103 þ CD11b þ intestinal DCs drive homeostatic Th17 cell differentiation, 4,38 a function associated with increased IL-12/IL-23 production. 39 Similarly, we observed that CD11c IL-23-mice had strongly reduced levels of IL-17A þ cells in the colonic lamina propria and low levels of constitutive Il23a were detected among þ MNPs resulted in more severe colitis and death in C. rodentiuminfected mice. 35 Together with our own data, these diverging results nicely illustrate that the functional sources of IL-23 that drive host protection or immune pathology vary and are not surprisingly highly context dependent. In our model, the development of colonic inflammation and histopathological changes induced by the noninvasive pathosymbiont Hh crucially depends on IL-23 production by CD11c þ cells. Induced Il23a expression is found at highest amounts in MHCII þ monocytes, which combined with their numerical dominance, suggests a major functional role of these cells in the pathogenesis of intestinal inflammation. However, given the ontogenic and phenotypical heterogeneity observed among the lamina propria CD11c þ MNP compartment during colitis and the difficulty to accurately distinguish CD11b þ DCs from macrophages because of their overlapping CD64 expression in inflammation, we cannot formally rule out a functional contribution of bona fide DCs in this model. Further studies specifically targeting the DC lineage will help to clarify this point.
Although IL-23 promotes Th17 responses, it is unclear whether IL-17 itself plays a pathogenic role in IL-10-deficient models of colitis. Indeed, IL-17A production by T cells was dispensable for T cell transfer colitis, 43 and neutralization of IL-17 was not sufficient to inhibit colitis in IL-10-deficient mice, being only partially protective when combined with anti-IL-6 treatment. 44 This suggests that IL-23 can drive IL-17-independent inflammatory pathways in the intestine. Our recent studies have suggested a key role for IL-23-driven granulocyte macrophage-CSF as a major downstream mediator that promotes chronic colitis through its ability to stimulate the myeloid cell response. 45 Others have shown that granulocyte macrophage-CSF can promote IL-23 production by MNPs, 46 suggesting a positive feedback loop that may contribute to T cell-mediated perpetuation of the innate inflammatory response.
Overall, our observation that intestinal CX 3 CR1-expressing CD11c þ cells are the major source of IL-23 in a physiological model of bacteria-driven colitis confirms the pathogenic potential of these cells during colitis and uncovers a novel mechanism through which they might perpetuate chronic inflammation. Further understanding of the functional sources of IL-23 in diverse forms of intestinal inflammation may lead to novel therapeutic strategies aimed at interrupting IL-23-driven immune pathology. GFP/ þ , 47 and Batf3 À / À 30 mice were bred and maintained under specific pathogen-free conditions in accredited animal facilities at the University of Oxford. Experiments were conducted in accordance with the UK Scientific Procedures Act (1986) under a Project License (PPL) authorized by the UK Home Office. Mice were routinely screened for the absence of pathogens and Helicobacter species and were over 5 weeks of age when used.
Induction of colitis. Hh NCI-Frederick isolate 1A (strain 51449) was grown as described previously. 48 Mice were fed on two consecutive days with Hh 1A (B1.0 Â 10 8 colony-forming units) by oral gavage and injected intraperitoneally with 1 mg anti-IL-10R (clone 1B1.2) mAb weekly, starting on day 0. Unless specified in the corresponding figures, mice were killed 2-3 weeks after infection.
Histology. Upon killing, samples of cecum and intact proximal, mid, and distal colon were fixed in phosphate-buffered 4% formalin. Next, 4-5 mm paraffin-embedded sections were stained with hematoxylin and eosin, and histopathology of the colon and cecum was assessed using a scoring system for epithelial hyperplasia, goblet cell depletion, leukocyte infiltration, and submucosal inflammation, as previously described. 48 Photomicrographs were taken using a Nikon Coolscope (Nikon, Tokyo, Japan).
Isolation of leukocytes. For lamina propria leukocyte isolation, the colon was opened longitudinally, washed, and cut into pieces. Pieces were washed twice in Hanks' balanced salt solution supplemented with 4% fetal bovine serum, 100 U ml À 1 penicillin/streptomycin, and 5 mM EDTA at 37 1C with shaking to remove epithelial cells. Tissue was then digested at 37 1C in a shaking incubator with 1 mg ml À 1 type VIII collagenase (Sigma-Aldrich, Gillingham, UK) and 0.5 mg ml À 1 DNase I in RPMI-1640 medium supplemented with 4% fetal bovine serum and 100 U ml À 1 penicillin/streptomycin. Cells were then layered on a 40/80% Percoll gradient, centrifuged, and the interface was recovered. Cells were counted using a Casy Cell Counter and Analyzer Model TT (Innovatis, Roche Diagnostics, Burgess Hill, UK).
Flow cytometry and cell sorting. For surface staining, cells were stained in phosphate-buffered saline/0.1% bovine serum albumin/ 5 mM EDTA buffer with a fixable viability dye and a combination of the following antibodies: CD45 (30-F11), CD11c (N418), MHCII (M5/ 114.15.2), F4/80 (BM8), and TCRb (H57-597) (all from eBioscience, Hatfield, UK); CD103 (M290), CD11b (M1/70), and Siglec-F (E50-2440) (all from BD Biosciences, Oxford, UK); Ly6G (1A8), Ly6C (HK1.4), CD64 (X54-5/7.1), CD4 (RM4-5), CD24 (M1/69), and CD206 (C068C2) (all from BioLegend, London, UK). Fc block (anti-CD16/CD32, eBioscience) was included to minimize nonspecific antibody binding. For intracellular cytokine staining of T cells, cells were incubated for 3.5 h in complete IMDM medium containing 0.1 mM phorbol 12-myristate 13-acetate and 1 mM ionomycin with 1:1,000 GolgiPlug and GolgiStop solutions (BD Biosciences) at 37 1C in a humidified incubator with 5% CO 2 . Following surface staining, cells were fixed and permeabilized with the Cytofix/Cytoperm Fixation/ Permeabilization Solution Kit (BD Biosciences) according to the manufacturer's instructions. Cells were stained for 50 min with antibodies to IL-17A (17B7, eBioscience) and IFNg (XMG1.2, eBioscience). All cells were analyzed on a SORP LSRII (BD Biosciences) or sorted on a FACSAriaIII (BD Biosciences) to a purity of 495%. Analysis was performed using FlowJo software (Tree Star, Ashland, OR).
Quantitative PCR. RNA was isolated from snap-frozen colonic tissue (combined proximal, mid, and distal colon sections), isolated lamina propria cells, BMDMs, or from FACS-sorted cells using the RNeasy Mini kit (QIAGEN, Manchester, UK) according to the manufacturer's instructions, including an on-column DNase I digestion step. Complementary DNA synthesis was performed using Superscript III reverse transcriptase (QIAGEN) or High-Capacity cDNA Reverse Transcriptase (Applied Biosystems, Life Technologies, Paisley, UK). Quantitative PCR reactions for the candidate genes were performed using TaqMan gene expression assays (Life Technologies). Complementary DNA samples were analyzed in duplicate using the CFX96 detection system (Bio-Rad Laboratories, Hemel Hempstead, UK) or ViiA 7 Real-Time PCR System (Life Technologies), and gene expression levels for each sample were normalized to HPRT. Mean relative gene expression was determined, and the differences were calculated using the 2DC(t) method. Primer pairs and probes were as follows: TaqMan Gene Expression Assays for mouse Hprt (Mm01545399_m1), Il23a (Mm00518984_m1), and (Mm01160011_g1).
Quantitation of cytokine protein levels. For detection of cytokines by the Flowcytomix Multiplex system (Life Technologies), 5 Â 10 5 leukocytes were cultured for 48 h in complete RPMI medium at 37 1C. Cytokines in the supernatant were detected using Simplex kits for mouse tumor necrosis factor-a, IL-1b, IL-17A, interferon-g (IFNg), and IL-22 according to the manufacturer's instructions and analyzed by flow cytometry. IL-23 protein levels were quantified using the mouse IL-23 ELISA Ready-SET-Go! kit (eBioscience).
Quantitation of H. hepaticus. Hh colonization levels were quantified in cecal contents collected upon killing. DNA was isolated using the DNA Stool kit (QIAGEN) and quantitative PCR with Hh-specific primers against the cdtB gene was performed as previously described. 48 Depletion of macrophages with anti-CSF-1R mAbs. Anti-CSF-1R mAb was purified from the culture supernatants of AFS98 hybridoma, kindly provided by Dr Miriam Merad (Mount Sinai School of Medicine, New York, NY). Mice were injected intraperitoneally with anti-CSF-1R mAb (AFS98) or rat IgG1 isotype control (HRPN, BioXcell, West Lebanon, NH) at doses of 1 mg per mouse on day À 4 followed by 0.3 mg per mouse from day À 3 to day 0. A group of mice was analyzed at day 0, whereas the remaining mice were infected with Hh and anti-IL-10R and continued to receive anti-CSF-1R treatment at 0.3 mg per mouse every second day until killing at day 4 or 14.
Statistics. Mann-Whitney U-test or one-way analysis of variance with Bonferroni's post-test correction was performed using GraphPad Prism version 6.02 for Windows (GraphPad Software, La Jolla, CA) as indicated. Differences were considered statistically significant when Po0.05.
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